在2型糖尿病患者中实施肝脏健康检查
Kushala W M Abeysekera1, Luca Valenti2, Zobair Younossi3
1Department of Population Health Sciences, Bristol Medical School, University of Bristol, UK; Department of Liver Medicine, Bristol Royal Infirmary, Bristol, UK.
在2型糖尿病患者中早期检测肝纤维化对于预防晚期肝病至关重要. 将肝脏健康检查纳入常规糖尿病护理中,可以识别有风险的个体,以便及时进行干预.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 由于可预防的肝病导致的全球发病率和死亡率不断上升,需要早期检测策略.
- 非酒精性脂肪性肝病 (NAFLD) 和与酒精有关的肝病需要及时识别才能有效管理.
- 肝硬化检测对于启动肝细胞癌和门性高血压监测至关重要.
研究的目的:
- 突出早期肝纤维化检测在预防晚期肝病中的重要性.
- 倡导将肝脏健康检查纳入2型糖尿病患者的日常护理.
- 强调2型糖尿病患者中晚期肝纤维化和NAFLD的高患病率.
主要方法:
- 审查目前用于早期检测肝病的策略.
- 在2型糖尿病人群中分析肝纤维化和NAFLD的患病率.
- 通过肝脏健康评估来增强现有的糖尿病护理框架的论点.
主要成果:
- 与一般人群相比,患有2型糖尿病的患者患有晚期肝纤维化 (高达19%) 和NAFLD (近70%) 的患病率明显高.
- 在常规的每年糖尿病检查中,肝脏健康常常被忽视.
- 整合肝脏健康检查可以促进早期检测和干预.
结论:
- 通过肝脏健康检查来加强糖尿病治疗,为早期检测晚期肝纤维化提供了关键的机会.
- 早期干预可以防止进展到末期肝病,包括肝细胞癌.
- 在2型糖尿病患者中,肝纤维化查应考虑在既定的护理框架内进行.
更多相关视频
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
